Pharmafile Logo

value

AI’s potential in the pharma life cycle

At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...

Why AI might be the rep’s best friend

When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Anthill Agency

Why we do it

Focussing on innovation

- PMLiVE

Prix Galien opens for entries with new award

2018 programme will include new medical technology category

- PMLiVE

PharmaLex strikes up AI collaboration with Volv

The duo will develop pharmacovigilance products and services

How to be a patient

Doctors are trained on how to manage their patients. Now Which? magazine has published a guide for patients on how to get the most out of their GP

Life Healthcare Communications

Are rare disease companies naturally more patient-centric?

Intuitively it would make sense for these firms to be more connected with their patients

- PMLiVE

Could ketamine be the next big thing in depression?

Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

Blue Latitude Health

Living with Lupus: Breaking the Silence

Published in eyeforpharma July 2017 by Mariel Metcalfe

Research Partnership

A healthcare landscape going through seismic change

Pfizer’s quest to generate health innovation as an ageing demographic threatens society’s ability to treat people

Perfecting the pharmaceutical pipeline with AI

How AI can transform the way we identify and validate research

- PMLiVE

Is it time we stopped talking about adherence?

Delivering a fresh approach to patient care

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links